Literature DB >> 11043622

Patient priorities with traumatic lacerations.

A J Singer1, C Mach, H C Thode, S Hemachandra, F S Shofer, J E Hollander.   

Abstract

Clinical trials should use outcomes that are important to patients. We sought to determine the aspects of laceration management that are most important to patients. A prospective observational survey was conducted at one suburban and one urban university ED during November to December 1998 that included ED patients and visitors with and without current or prior lacerations. Trained research assistants approached 747 people of which 724 (97%) completed a 25-item closed question survey that evaluated demographics, prior laceration repairs, and assessed the relative importance of least painful repair, ED length of stay, cosmetic outcome, functional recovery, practitioner compassion, avoidance of wound infection, total costs, and missed days of work or school using a five-item Likert scale (not important-extremely important). Additionally, the relative importance of these items was compared. Data were analyzed with descriptive statistics and 95% confidence intervals (CIs). Seven hundred twenty-four people participated; 383 (53%) had prior lacerations; 92 (14%) had lacerations at the time of the survey. The most important aspect of care for respondents were normal function (28%), avoiding infection (20%), cosmetic outcome (17%), and least painful repair (17%). Based on Likert scale data, most important aspects of care were: avoiding wound infection (mean [95% CI], 4.58 [4.52 to 4.64]), normal function (4.54 [4.48 to 4.6]), cosmetic outcome (3.78 [3.68 to 3.88]), and least painful repair (3.84 [3.76 to 3.92]). Cost, length of stay, missed work/school, and compassion were less important (range, 3.0 to 3.7). Patients with facial lacerations chose cosmetic outcome as the most important aspect of care while all others chose function. Patients prioritize the medical outcomes of laceration repair (function, avoiding infection, cosmesis, pain) more than cost, compassion, ED length of stay and inconvenience (missed work/school). Cosmetic outcome is particularly important to patients with facial lacerations. This information should be useful when designing outcome studies of laceration management.

Entities:  

Mesh:

Year:  2000        PMID: 11043622     DOI: 10.1053/ajem.2000.16312

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  7 in total

Review 1.  A descriptive review on methods to prioritize outcomes in a health care context.

Authors:  Inger M Janssen; Ansgar Gerhardus; Milly A Schröer-Günther; Fülöp Scheibler
Journal:  Health Expect       Date:  2014-08-25       Impact factor: 3.377

2.  Head and Neck Injuries Associated With Cell Phone Use.

Authors:  Roman Povolotskiy; Nakul Gupta; Adam B Leverant; Aron Kandinov; Boris Paskhover
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-02-01       Impact factor: 6.223

3.  The risk of wound infection after simple hand laceration.

Authors:  Gholamreza S Roodsari; Farhad Zahedi; Shahriar Zehtabchi
Journal:  World J Emerg Med       Date:  2015

4.  Repigmentation of cutaneous scars depends on original wound type.

Authors:  Sarah L Chadwick; Christina Yip; Mark W J Ferguson; Mamta Shah
Journal:  J Anat       Date:  2013-05-14       Impact factor: 2.610

5.  Development of a Plastic Surgery Supply Cart: Patient Outcomes and Quality of Care.

Authors:  Matthew P Fahrenkopf; Mitchell G Eichhorn
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-02-08

6.  Early Complications Following Facial Laceration Repair Performed by Emergency Physicians After One Year of Wound Closure Training.

Authors:  Ryo Yamamoto; Koichiro Homma; Yuya Masuzawa; Chikako Shimizu; Toshio Ogata; Shingo Hori; Junichi Sasaki
Journal:  AEM Educ Train       Date:  2018-08-16

7.  Satisfaction with facial laceration repair by provider specialty in the emergency department.

Authors:  Sang-Jae Lee; Young-Duck Cho; Sung-Jun Park; Jung-Youn Kim; Young-Hoon Yoon; Sung-Hyuk Choi
Journal:  Clin Exp Emerg Med       Date:  2015-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.